SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-15-005814
Filing Date
2015-09-10
Accepted
2015-09-10 13:50:24
Documents
11
Period of Report
2015-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pvotf_10q.htm 10-Q 276446
2 CERTIFICATION pvotf_ex311.htm EX-31.1 8010
3 CERTIFICATION pvotf_ex312.htm EX-31.2 8085
4 CERTIFICATION pvotf_ex321.htm EX-32.1 4262
5 CERTIFICATION pvotf_ex322.htm EX-32.2 4158
  Complete submission text file 0001477932-15-005814.txt   1492164

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pvotf-20150731.xml EX-101.INS 195906
7 XBRL TAXONOMY EXTENSION SCHEMA pvotf-20150731.xsd EX-101.SCH 27870
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pvotf-20150731_cal.xml EX-101.CAL 28621
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pvotf-20150731_def.xml EX-101.DEF 36278
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pvotf-20150731_lab.xml EX-101.LAB 143057
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pvotf-20150731_pre.xml EX-101.PRE 96651
Mailing Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6
Business Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6 604 805 7783
Pivot Pharmaceuticals Inc. (Filer) CIK: 0001464165 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-161157 | Film No.: 151100845
SIC: 2834 Pharmaceutical Preparations